MONDAY, June 9, 2025 (HealthDay News) — Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new clinical trial shows. Patients prescribed the combination of finerenone and empagliflozin experienced a 52% decrease in their urinary albumin-to-creatinine ratio, researchers report inContinue Reading

FRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a new clinical trial has found. Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis,Continue Reading